BackIntellia Therapeutics Overview

Intellia Therapeutics Gross Profit

Gross Profit analysis for NTLA.

Quarterly Gross Profit

$12.85M
↓ 22.74% YoY

As of Mar 31, 2026

Annual Gross Profit (TTM)

$27.09M
↓ 37% YoY

Trailing 12 months ending Mar 31, 2026

Average Gross Profit (Comparison Companies)

Gross Profit History

Gross Profit Comparison

Annual Gross Profit Growth Rate (%)

Annual Gross Profit Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin